Designed for advanced Parkinson’s with poorly controlled motor fluctuations, the infusion delivers steadier levodopa exposure than pills via continuous subcutaneous dosing.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-backs-continuous-infusion-levodopa-parkinsons-2026a100068v?src=rss
Author :
Publish date : 2026-02-27 17:02:00
Copyright for syndicated content belongs to the linked Source.